EarningsQ4 2026 Earnings Report
MX:SOONN Q4 2026 EPS Results
Actual EPS$125.84
Consensus EPS$126.64
Beat/MissMissed by -$0.80
One Year Ago EPS$156.92
MX:SOONN Q4 2026 Revenue Results
Actual Revenue$39.74B
Expected Revenue$43.58B
Beat/MissMissed by -$3.84B
YoY Revenue Growth-11.89%
Earnings Announcement Details
QuarterQ4 2026
Date05/18/2026
TimeBefore Open
Conference CallMonday, May 18, 2026
MX:SOONN Upcoming Earnings
Sonova Holding AG's next earnings date is estimated for November 12, 2026, based on past reporting schedules.
Q4 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2026 Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented a clearly positive operational and financial picture: above-market sales growth, strong wholesale momentum and market-share gains, significant margin expansion, robust cash conversion and a confident guidance range. Key negatives are concentrated in the Cochlear Implants business (declining sales and margins), substantial non‑recurring charges and FX headwinds, and timing/regulatory risk around the planned CI product launch. On balance, the company showed broad-based momentum and multiple levers (product pipeline, retail M&A, efficiency initiatives) to drive future growth, outweighing the identified headwinds.Company Guidance
Above-market Sales Growth and Confirmed Guidance
Group delivered above-market sales growth across all regions, exited the year with sequential Q4 momentum and provided FY26/27 guidance of consolidated sales rising 5% to 8% and core EBIT growth of 7% to 10% at constant exchange rates.
Hearing Instruments Segment: Strong Revenue and Margin Expansion
Hearing Instruments sales rose 7.5% to CHF 3.4 billion; normalized EBITDA increased 17.3% to CHF 794 million, delivering a 23.7% margin and a margin improvement of ~280 basis points in local currencies.
Wholesale: Double-digit Second-half Growth and Market-share Gains
Wholesale revenues increased 9.5% (CHF 1.9 billion) with H2 growth of 10.9%; management reported the largest year‑on‑year market share gain since the Marvel platform launch and highlighted Virto R (now ~CHF 120 million p.a. run‑rate from zero) and Infinio Ultra as major contributors.
Retail: Steady Organic Growth and Strategic Expansion
Retail revenues reached CHF 1.5 billion, up 5.1%; bolt-on acquisitions contributed ~1.3 percentage points to growth, with store expansions in Germany, Austria and Canada and sequential acceleration in Q4.
Strong Profitability, Operating Leverage and Capital Metrics
Normalized EBITA rose 17.3% (almost 3x faster than top line) with a margin improvement of ~240 basis points in local currencies; EPS grew ~16%; return on capital employed remained strong at 19%; net debt/EBITDA improved to 1.1x.
Product Innovation and Pipeline Momentum
Launched AI-driven products (Sphere, Sphere Ultra), Virto R rechargeable ITE and EasyGuard wax management; management plans a new AI-enabled hearing aid platform in FY26/27 and a new cochlear-implant sound processor to drive future growth.
Healthy Cash Generation and Disciplined Capital Allocation
Operating free cash flow and cash conversion remained strong (consistently above 90%); disciplined capex (lower than prior year); cash spent on bolt-on retail acquisitions CHF 46 million; stable working capital trends.
Recognized Sustainability Progress
Sonova continued to be recognized by leading ESG rating agencies and included in important sustainability indices, underlining progress on its sustainability agenda.
MX:SOONN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed